Masimo Corporation
Masimo Corporation Adopts New Bylaws
Summary
On February 12, 2025, Masimo Corporation's board of directors approved and adopted the Company's Sixth Amended and Restated Bylaws, effective as of the same date. The Restated Bylaws include provisions such as the right to call a special meeting for stockholders holding at least 20% of the voting power, reducing the threshold for stockholder-approved amendments to the bylaws, and changing the period for submitting stockholder nominations of directors. The 2025 Annual Meeting of Stockholders is scheduled for April 29, 2025, with proposals and nominations due by March 1, 2025.
Profitelligence Alerts
Get alerts for MASI
Be first to know when Masimo Corporation files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Masimo Corporation
Masimo Corporation is a global leader in noninvasive monitoring technologies, specifically focusing on developing innovative medical devices that improve patient outcomes and reduce the cost of care. The company's flagship product line includes advanced signal processing pulse oximetry devices, which are pivotal in accurately measuring oxygen levels, pulse rate, and other vital signals without the need for invasive procedures. Masimo's technology is widely adopted across various healthcare settings including hospitals, outpatient treatment centers, and alternative care sites, enhancing patient monitoring and aiding clinicians in detecting potential health issues more efficiently. Besides, Masimo’s products are recognized for their precision and reliability, demonstrating robustness even in challenging clinical environments where motion and low perfusion can affect monitoring accuracy. The corporation is committed to expanding its technological suite, covering a spectrum of health monitoring solutions that contribute to improved healthcare practices globally. Based in Irvine, California, Masimo's ongoing innovation continues to set benchmarks in the healthcare industry, influencing a wide range of sectors from emergency care to surgical and critical care monitoring.
Official SEC Documents
Advertisement